LFAS
BCRX icon

Level Four Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Level Four Advisory Services’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,681
Closed -$645K – 564
2022
Q1 		$645K Buy
+39,681
New +$645K 0.05% 331